← All trials
NCT06081153
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2023
- Primary completion
- Nov 1, 2028
- Completion date
- Nov 1, 2028
- First posted
- Oct 13, 2023
- Last posted
- Oct 16, 2023
- Enrollment
- 44
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PennsylvaniaLead sponsor
- AmgenCollaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- University of PennsylvaniaOverall official - principal investigator
- University of PennsylvaniaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.